Oropharyngeal and nasopharyngeal decontamination with chlorhexidine gluconate in lung cancer surgery: a randomized clinical trial.

Date publication

avril 2018

Journal

Intensive care medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel

Tous les auteurs :
D'Journo XB, Falcoz PE, Alifano M, Le Rochais JP, D'Annoville T, Massard G, Regnard JF, Icard P, Marty-Ane C, Trousse D, Doddoli C, Orsini B, Edouard S, Million M, Lesavre N, Loundou A, Baumstarck K, Peyron F, Honoré S, Dizier S, Charvet A, Leone M, Raoult D, Papazian L, Thomas PA

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29671041

Résumé

Respiratory complications are the leading causes of morbidity and mortality after lung cancer surgery. We hypothesized that oropharyngeal and nasopharyngeal decontamination with chlorhexidine gluconate (CHG) would be an effective method to reduce these complications as reported in cardiac surgery.

Mots clés

Chlorhexidine gluconate, Hospital-acquired infection, Infection, Lung cancer, Mechanical ventilation, Noninvasive ventilation, Pneumonia, Surgery, Video-assisted thoracic surgery

Référence

Intensive Care Med. 2018 Apr 18;: